Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor
Cecylia S. Lupala, Yongjin Ye, Hong Chen, et al.
Biochemical and Biophysical Research Communications (2021) Vol. 590, pp. 34-41
Open Access | Times Cited: 206

Showing 26-50 of 206 citing articles:

The wave of the SARS-CoV-2 Omicron variant resulted in a rapid spike and decline as highlighted by municipal wastewater surveillance
Francesca Cutrupi, Maria Cadonna, Serena Manara, et al.
Environmental Technology & Innovation (2022) Vol. 28, pp. 102667-102667
Open Access | Times Cited: 27
Therapeutics to Tackle Omicron Outbreak
Vivek P. Chavda, Eswara Naga Hanuma Kumar Ghali, Murali M. Yallapu, et al.
Immunotherapy (2022) Vol. 14, Iss. 11, pp. 833-838
Open Access | Times Cited: 27
SARS-CoV-2 Spike N-Terminal Domain Engages 9-O-Acetylated α2–8-Linked Sialic Acids
Ilhan Tomris, Luca Unione, Linh Nguyen, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 5, pp. 1180-1191
Open Access | Times Cited: 17
Omicron Coronavirus: pH-Dependent Electrostatic Potential and Energy of Association of Spike Protein to ACE2 Receptor
S. Hristova, Alexandar M. Zhivkov
Viruses (2023) Vol. 15, Iss. 8, pp. 1752-1752
Open Access | Times Cited: 16
Inhibition of multiple SARS-CoV-2 variants entry by Lycium barbarum L. polysaccharides through disruption of spike protein-ACE2 interaction
Jingxuan Li, Feng Liu, Fushan Wu, et al.
International Journal of Biological Macromolecules (2024), pp. 129785-129785
Closed Access | Times Cited: 4
Global Distribution, Dispersal Patterns, and Trend of Several Omicron Subvariants of SARS-CoV-2 across the Globe
Ioannis Kopsidas, Sofia Karagiannidou, Evangelia Georgia Kostaki, et al.
Tropical Medicine and Infectious Disease (2022) Vol. 7, Iss. 11, pp. 373-373
Open Access | Times Cited: 24
Evolution and Clinical Trend of SARS-CoV-2 Variants
Miguel Lorente-González, Miguel Suarez-Ortiz, Pedro Landete
Open Respiratory Archives (2022) Vol. 4, Iss. 2, pp. 100169-100169
Open Access | Times Cited: 23
SARS-CoV-2 variants of concern alpha, beta, gamma and delta have extended ACE2 receptor host ranges
Nazia Thakur, Giulia Gallo, Joseph Newman, et al.
Journal of General Virology (2022) Vol. 103, Iss. 4
Open Access | Times Cited: 23
An in-silico study of the mutation-associated effects on the spike protein of SARS-CoV-2, Omicron variant
Tushar Ahmed Shishir, Taslimun Jannat, Iftekhar Bin Naser
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0266844-e0266844
Open Access | Times Cited: 23
A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection
Juan Shi, Jian Zheng, Wanbo Tai, et al.
Journal of Virology (2022) Vol. 96, Iss. 17
Open Access | Times Cited: 23
Variants of SARS CoV-2: mutations, transmissibility, virulence, drug resistance, and antibody/vaccine sensitivity
Birgit M. Prü
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 2, pp. 065-065
Open Access | Times Cited: 22
Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review
K. Akash, Avinash Sharma, Deepak Kumar, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 4628-4643
Open Access | Times Cited: 22
Comparative Binding Ability of Human Monoclonal Antibodies against Omicron Variants of SARS-CoV-2: An In Silico Investigation
Nabarun Chandra Das, Pritha Chakraborty, Jagadeesh Bayry, et al.
Antibodies (2023) Vol. 12, Iss. 1, pp. 17-17
Open Access | Times Cited: 13
The SARS‐CoV‐2 Omicron Variant and its Multiple Sub‐lineages: Transmissibility, Vaccine Development, Antiviral Drugs, Monoclonal Antibodies, and Strategies for Infection Control – a Review
Ranjan K. Mohapatra, Sarika Verma, Venkataramana Kandi, et al.
ChemistrySelect (2023) Vol. 8, Iss. 9
Open Access | Times Cited: 13
Point-of-care testing of infectious diseases: recent advances
Mei-Yun Shang, Jiuchuan Guo, Jinhong Guo
Sensors & Diagnostics (2023) Vol. 2, Iss. 5, pp. 1123-1144
Open Access | Times Cited: 13
Molecular mechanisms and cellular functions of liquid-liquid phase separation during antiviral immune responses
Shuai Yang, Weishan Shen, Jiajia Hu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Investigation of some plant stilbenoids and their fragments for the identification of inhibitors of SARS-CoV-2 viral spike/ACE2 protein binding
Cyril T. Namba-Nzanguim, Conrad V. Simoben, Boris D. Bekono, et al.
The Microbe (2024) Vol. 3, pp. 100059-100059
Open Access | Times Cited: 4
SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines
Camilo C. Roa, Mari Rose A de Los Reyes, Eric Plennevaux, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Gut microbiota and metabolites in patients with COVID-19 are altered by the type of SARS-CoV-2 variant
Yoshihiro Yokoyama, Tomoko Ichiki, Tsukasa Yamakawa, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 3
Clinical characteristics of pediatric patients with COVID-19 between Omicron era vs. pre-Omicron era
Hiroyuki Iijima, M. Kubota, Chikara Ogimi
Journal of Infection and Chemotherapy (2022) Vol. 28, Iss. 11, pp. 1501-1505
Open Access | Times Cited: 20
Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination
Francesca Dapporto, Serena Marchi, Margherita Leonardi, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 20
Electrostatic Interactions Are the Primary Determinant of the Binding Affinity of SARS-CoV-2 Spike RBD to ACE2: A Computational Case Study of Omicron Variants
Peng Sang, Yongqin Chen, Meng-Ting Liu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14796-14796
Open Access | Times Cited: 20
Evaluation of the Panbio COVID-19 Antigen Rapid Diagnostic Test in Subjects Infected with Omicron Using Different Specimens
Rafael Mello Galliez, Larissa Bomfim, Diana Mariani, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 19
Probing Mechanisms of Binding and Allostery in the SARS-CoV-2 Spike Omicron Variant Complexes with the Host Receptor: Revealing Functional Roles of the Binding Hotspots in Mediating Epistatic Effects and Communication with Allosteric Pockets
Gennady M. Verkhivker, Steve Agajanian, Ryan Kassab, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11542-11542
Open Access | Times Cited: 19
Deciphering the Impact of Mutations on the Binding Efficacy of SARS-CoV-2 Omicron and Delta Variants With Human ACE2 Receptor
Alamgir Khan, Salman Ali Khan, Komal Zia, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 18

Scroll to top